BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 22, 2026

  April 23, 2026

   · 

  1 min read
• Press Releases

  LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia

  April 23, 2026

   · 

  6 min read
• Press Releases

  Teknova to Report First Quarter 2026 Financial Results on May 6, 2026

  April 23, 2026

   · 

  1 min read
• Press Releases

  Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor

  April 23, 2026

   · 

  11 min read
• Press Releases

  XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation

  April 23, 2026

   · 

  3 min read
• Press Releases

  ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

  April 23, 2026

   · 

  6 min read
• Press Releases

  Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Showing Sustained Glucocorticoid Dose Reductions While Maintaining Androgen Control in Adults with Classic Congenital Adrenal Hyperplasia

  April 23, 2026

   · 

  13 min read
• Press Releases

  GRAIL to Announce First Quarter 2026 Financial Results

  April 23, 2026

   · 

  1 min read
• Press Releases

  AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER

  April 23, 2026

   · 

  9 min read
• Press Releases

  Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day

  April 23, 2026

   · 

  9 min read